Aytu Biopharma (AYTU) Other Non Operating Income (2015 - 2026)
Aytu Biopharma (AYTU) posted quarterly Other Non Operating Income of $149000.0 for Q1 2026, up 313.89% year-over-year from $36000.0 in Q1 2025, and down 21.58% quarter-over-quarter from $190000.0 in Q4 2025.
Aytu Biopharma (AYTU) Other Non Operating Income (2015 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Other Non Operating Income for 12 consecutive years, with $149000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non Operating Income rose 313.89% year-over-year to $149000.0; the TTM figure through Mar 2026 stood at $5.4 million (up 120.81% YoY), while the FY2024 annual figure was -$594000.0, down 422.83% from the prior year.
- Other Non Operating Income retreated to $149000.0 in Q1 2026 per AYTU's latest filing, from $190000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $3.8 million in Q3 2025 and bottomed at -$5.9 million in Q3 2023.
- Historically, Other Non Operating Income has averaged $645823.5 across 5 years, with a median of $149000.0 in 2026.
- Annual changes were most pronounced in 2022 — Other Non Operating Income sank 377.82% — and 2023, when it surged 36857.14%.
- Aytu Biopharma's Other Non Operating Income stood at -$1.2 million in 2022, then soared by 107.82% to $96000.0 in 2023, then soared by 45.83% to $140000.0 in 2024, then jumped by 35.71% to $190000.0 in 2025, then decreased by 21.58% to $149000.0 in 2026.
- Business Quant data shows AYTU's Other Non Operating Income at $149000.0 in Q1 2026, $190000.0 in Q4 2025, and $3.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Aytu Biopharma | 24.86 Mn | -1.86 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 149,000.00 |
| Dec 31, 2025 | 190,000.00 |
| Sep 30, 2025 | 3.78 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Mar 31, 2025 | 36,000.00 |
| Dec 31, 2024 | 140,000.00 |
| Sep 30, 2024 | 2.88 Mn |
| Jun 30, 2024 | -600,000.00 |
| Mar 31, 2024 | 70,000.00 |
| Dec 31, 2023 | 96,000.00 |
| Sep 30, 2023 | -5.91 Mn |
| Jun 30, 2023 | 3.71 Mn |
| Mar 31, 2023 | 2.57 Mn |
| Dec 31, 2022 | -1.23 Mn |
| Sep 30, 2022 | 2.19 Mn |
| Jun 30, 2022 | 1.60 Mn |
| Mar 31, 2022 | -7,000.00 |
| Dec 31, 2021 | -257,000.00 |
| Sep 30, 2021 | -40,000.00 |
| Jun 30, 2021 | -495,000.00 |